Currently, Revolution Medicines Inc [RVMD] is trading at $45.28, up 4.45%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RVMD shares have gain 6.34% over the last week, with a monthly amount drifted -3.19%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on July 16, 2024, when Needham reiterated its Buy rating and also boosted its price target to $62 from $46. Previously, Barclays started tracking the stock with Overweight rating on July 12, 2024, and set its price target to $52. On July 08, 2024, Jefferies initiated with a Buy rating and assigned a price target of $63 on the stock. Needham reiterated its Buy rating and increased its price target to $46 on April 12, 2024. Raymond James upgraded its rating to a Strong Buy and raised its price target to $48 on April 10, 2024. Piper Sandler started tracking with a Overweight rating for this stock on March 11, 2024, and assigned it a price target of $43. In a note dated January 05, 2024, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $31 to $34.
This stock has fluctuated between a low of $15.44 and a high of $48.61 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $51.2 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $45.28 at the most recent close of the market. An investor can expect a potential return of 13.07% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
Trailing Twelve Months sales for Revolution Medicines Inc [NASDAQ:RVMD] were 0.74M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at -13.24% with Operating Profit Margin at -809.61%, Pretax Profit Margin comes in at -704.49%, and Net Profit Margin reading is -699.74%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.35 and Total Capital is -0.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 43.97 points at the first support level, and at 42.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.22, and for the 2nd resistance point, it is at 47.16.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Revolution Medicines Inc [NASDAQ:RVMD] is 15.42. Also, the Quick Ratio is 15.42, while the Cash Ratio stands at 2.62. Considering the valuation of this stock, the price to sales ratio is 10221.04, the price to book ratio is 4.63.
Transactions by insiders
Recent insider trading involved BARBARA L WEBER, Officer, that happened on Aug 21 ’24 when 1808.0 shares were purchased., Kelsey Stephen Michael completed a deal on Aug 13 ’24 to sell 16667.0 shares. Meanwhile, Officer STEPHEN M. KELSEY bought 16667.0 shares on Aug 13 ’24.
